Washington, DC: American Pharmaceutical Association
CagriSema: Activating amylin and GLP-1 receptors CagriSema from Novo Nordisk activates both GLP-1 and amylin receptors
Stephanie Weiss, M.D., Ph.D., assistant director for the Clinical Research, Medication Development Program at NIDA, shared data from the first published clinical trial of GLP-1 RAs in alcohol use disorder: in patients with obesity with a BMI over 30, exenatide reduced heavy drinking days by 23.6% and lowered total alcohol intake
Hofseth BioCares (from The Netherlands) ProGo , a protein hydrolysate from Atlantic salmon , uses a proprietary enzymatic process to produce small peptides that activate GLP-1 receptors
For those curious about how it compares to other options or what side effects to expect, looking at user reviews for semaglutide and personal stories can be helpful
We call it the the 7 Nos. Those private brand items are free from artificial flavors, artificial preservatives, artificial sweeteners, synthetic colors, MSG, high-fructose corn syrup and hydrogenated or partially hydronated oils